 | • レポートコード：MRC2-11QY11000 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は無血管性壊死（AVN）のグローバル市場について調査・分析したレポートです。種類別（外傷関連無血管壊死（AVN）、非外傷関連無血管壊死（AVN））市場規模、用途別（病院、診療所、診断センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別無血管性壊死（AVN）の競争状況、市場シェア ・世界の無血管性壊死（AVN）市場：種類別市場規模 2015年-2020年（外傷関連無血管壊死（AVN）、非外傷関連無血管壊死（AVN）） ・世界の無血管性壊死（AVN）市場：種類別市場規模予測 2021年-2026年（外傷関連無血管壊死（AVN）、非外傷関連無血管壊死（AVN）） ・世界の無血管性壊死（AVN）市場：用途別市場規模 2015年-2020年（病院、診療所、診断センター、外来手術センター） ・世界の無血管性壊死（AVN）市場：用途別市場規模予測 2021年-2026年（病院、診療所、診断センター、外来手術センター） ・北米の無血管性壊死（AVN）市場分析：米国、カナダ ・ヨーロッパの無血管性壊死（AVN）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの無血管性壊死（AVN）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の無血管性壊死（AVN）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの無血管性壊死（AVN）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Stryker、Medtronic、Smith and Nephew、Ethicon、Sanofi、Bayer、Pfizer、Merck、Boehringer Ingelheim、Eli Lilly、Aurobindo Pharma、Integra LifeSciences、Zimmer Biomet、Wright Medical、Grifols ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby joint surface.
Known by other names such as osteonecrosis or bone infarction, the condition is gaining global awareness thus supporting the growth of the AVN market. The disease which more commonly afflicts men between the ages of 30 to 50 years, has been highly prevalent in emerging economies.
Market Analysis and Insights: Global Avascular Necrosis Market
The global Avascular Necrosis market size is projected to reach US$ 491.2 million by 2026, from US$ 473.8 million in 2020, at a CAGR of 3.4%% during 2021-2026.
Global Avascular Necrosis Scope and Market Size
Avascular Necrosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Avascular Necrosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Stryker
Medtronic
Smith and Nephew
Ethicon
Sanofi
Bayer
Pfizer
Merck
Boehringer Ingelheim
Eli Lilly
Aurobindo Pharma
Integra LifeSciences
Zimmer Biomet
Wright Medical
Grifols
Market segment by Type, the product can be split into
Trauma Related Avascular Necrosis (AVN)
Non-Trauma Related Avascular Necrosis (AVN)
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Avascular Necrosis Revenue
1.4 Market by Type
1.4.1 Global Avascular Necrosis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Trauma Related Avascular Necrosis (AVN)
1.4.3 Non-Trauma Related Avascular Necrosis (AVN)
1.5 Market by Application
1.5.1 Global Avascular Necrosis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Avascular Necrosis Market Perspective (2015-2026)
2.2 Global Avascular Necrosis Growth Trends by Regions
2.2.1 Avascular Necrosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Avascular Necrosis Historic Market Share by Regions (2015-2020)
2.2.3 Avascular Necrosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Avascular Necrosis Market Growth Strategy
2.3.6 Primary Interviews with Key Avascular Necrosis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Avascular Necrosis Players by Market Size
3.1.1 Global Top Avascular Necrosis Players by Revenue (2015-2020)
3.1.2 Global Avascular Necrosis Revenue Market Share by Players (2015-2020)
3.1.3 Global Avascular Necrosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Avascular Necrosis Market Concentration Ratio
3.2.1 Global Avascular Necrosis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Avascular Necrosis Revenue in 2019
3.3 Avascular Necrosis Key Players Head office and Area Served
3.4 Key Players Avascular Necrosis Product Solution and Service
3.5 Date of Enter into Avascular Necrosis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Avascular Necrosis Historic Market Size by Type (2015-2020)
4.2 Global Avascular Necrosis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Avascular Necrosis Market Size by Application (2015-2020)
5.2 Global Avascular Necrosis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Avascular Necrosis Market Size (2015-2020)
6.2 Avascular Necrosis Key Players in North America (2019-2020)
6.3 North America Avascular Necrosis Market Size by Type (2015-2020)
6.4 North America Avascular Necrosis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Avascular Necrosis Market Size (2015-2020)
7.2 Avascular Necrosis Key Players in Europe (2019-2020)
7.3 Europe Avascular Necrosis Market Size by Type (2015-2020)
7.4 Europe Avascular Necrosis Market Size by Application (2015-2020)
8 China
8.1 China Avascular Necrosis Market Size (2015-2020)
8.2 Avascular Necrosis Key Players in China (2019-2020)
8.3 China Avascular Necrosis Market Size by Type (2015-2020)
8.4 China Avascular Necrosis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Avascular Necrosis Market Size (2015-2020)
9.2 Avascular Necrosis Key Players in Japan (2019-2020)
9.3 Japan Avascular Necrosis Market Size by Type (2015-2020)
9.4 Japan Avascular Necrosis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Avascular Necrosis Market Size (2015-2020)
10.2 Avascular Necrosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Avascular Necrosis Market Size by Type (2015-2020)
10.4 Southeast Asia Avascular Necrosis Market Size by Application (2015-2020)
11 India
11.1 India Avascular Necrosis Market Size (2015-2020)
11.2 Avascular Necrosis Key Players in India (2019-2020)
11.3 India Avascular Necrosis Market Size by Type (2015-2020)
11.4 India Avascular Necrosis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Avascular Necrosis Market Size (2015-2020)
12.2 Avascular Necrosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Avascular Necrosis Market Size by Type (2015-2020)
12.4 Central & South America Avascular Necrosis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Stryker
13.1.1 Stryker Company Details
13.1.2 Stryker Business Overview
13.1.3 Stryker Avascular Necrosis Introduction
13.1.4 Stryker Revenue in Avascular Necrosis Business (2015-2020))
13.1.5 Stryker Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview
13.2.3 Medtronic Avascular Necrosis Introduction
13.2.4 Medtronic Revenue in Avascular Necrosis Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 Smith and Nephew
13.3.1 Smith and Nephew Company Details
13.3.2 Smith and Nephew Business Overview
13.3.3 Smith and Nephew Avascular Necrosis Introduction
13.3.4 Smith and Nephew Revenue in Avascular Necrosis Business (2015-2020)
13.3.5 Smith and Nephew Recent Development
13.4 Ethicon
13.4.1 Ethicon Company Details
13.4.2 Ethicon Business Overview
13.4.3 Ethicon Avascular Necrosis Introduction
13.4.4 Ethicon Revenue in Avascular Necrosis Business (2015-2020)
13.4.5 Ethicon Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Avascular Necrosis Introduction
13.5.4 Sanofi Revenue in Avascular Necrosis Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Avascular Necrosis Introduction
13.6.4 Bayer Revenue in Avascular Necrosis Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Avascular Necrosis Introduction
13.7.4 Pfizer Revenue in Avascular Necrosis Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Avascular Necrosis Introduction
13.8.4 Merck Revenue in Avascular Necrosis Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Details
13.9.2 Boehringer Ingelheim Business Overview
13.9.3 Boehringer Ingelheim Avascular Necrosis Introduction
13.9.4 Boehringer Ingelheim Revenue in Avascular Necrosis Business (2015-2020)
13.9.5 Boehringer Ingelheim Recent Development
13.10 Eli Lilly
13.10.1 Eli Lilly Company Details
13.10.2 Eli Lilly Business Overview
13.10.3 Eli Lilly Avascular Necrosis Introduction
13.10.4 Eli Lilly Revenue in Avascular Necrosis Business (2015-2020)
13.10.5 Eli Lilly Recent Development
13.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Details
10.11.2 Aurobindo Pharma Business Overview
10.11.3 Aurobindo Pharma Avascular Necrosis Introduction
10.11.4 Aurobindo Pharma Revenue in Avascular Necrosis Business (2015-2020)
10.11.5 Aurobindo Pharma Recent Development
13.12 Integra LifeSciences
10.12.1 Integra LifeSciences Company Details
10.12.2 Integra LifeSciences Business Overview
10.12.3 Integra LifeSciences Avascular Necrosis Introduction
10.12.4 Integra LifeSciences Revenue in Avascular Necrosis Business (2015-2020)
10.12.5 Integra LifeSciences Recent Development
13.13 Zimmer Biomet
10.13.1 Zimmer Biomet Company Details
10.13.2 Zimmer Biomet Business Overview
10.13.3 Zimmer Biomet Avascular Necrosis Introduction
10.13.4 Zimmer Biomet Revenue in Avascular Necrosis Business (2015-2020)
10.13.5 Zimmer Biomet Recent Development
13.14 Wright Medical
10.14.1 Wright Medical Company Details
10.14.2 Wright Medical Business Overview
10.14.3 Wright Medical Avascular Necrosis Introduction
10.14.4 Wright Medical Revenue in Avascular Necrosis Business (2015-2020)
10.14.5 Wright Medical Recent Development
13.15 Grifols
10.15.1 Grifols Company Details
10.15.2 Grifols Business Overview
10.15.3 Grifols Avascular Necrosis Introduction
10.15.4 Grifols Revenue in Avascular Necrosis Business (2015-2020)
10.15.5 Grifols Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Avascular Necrosis Key Market Segments
Table 2. Key Players Covered: Ranking by Avascular Necrosis Revenue
Table 3. Ranking of Global Top Avascular Necrosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Avascular Necrosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Trauma Related Avascular Necrosis (AVN)
Table 6. Key Players of Non-Trauma Related Avascular Necrosis (AVN)
Table 7. Global Avascular Necrosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Avascular Necrosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Avascular Necrosis Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Avascular Necrosis Market Share by Regions (2015-2020)
Table 11. Global Avascular Necrosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Avascular Necrosis Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Avascular Necrosis Market Growth Strategy
Table 17. Main Points Interviewed from Key Avascular Necrosis Players
Table 18. Global Avascular Necrosis Revenue by Players (2015-2020) (Million US$)
Table 19. Global Avascular Necrosis Market Share by Players (2015-2020)
Table 20. Global Top Avascular Necrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avascular Necrosis as of 2019)
Table 21. Global Avascular Necrosis by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Avascular Necrosis Product Solution and Service
Table 24. Date of Enter into Avascular Necrosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 27. Global Avascular Necrosis Market Size Share by Type (2015-2020)
Table 28. Global Avascular Necrosis Revenue Market Share by Type (2021-2026)
Table 29. Global Avascular Necrosis Market Size Share by Application (2015-2020)
Table 30. Global Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 31. Global Avascular Necrosis Market Size Share by Application (2021-2026)
Table 32. North America Key Players Avascular Necrosis Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Avascular Necrosis Market Share (2019-2020)
Table 34. North America Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 35. North America Avascular Necrosis Market Share by Type (2015-2020)
Table 36. North America Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 37. North America Avascular Necrosis Market Share by Application (2015-2020)
Table 38. Europe Key Players Avascular Necrosis Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Avascular Necrosis Market Share (2019-2020)
Table 40. Europe Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Avascular Necrosis Market Share by Type (2015-2020)
Table 42. Europe Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Avascular Necrosis Market Share by Application (2015-2020)
Table 44. China Key Players Avascular Necrosis Revenue (2019-2020) (Million US$)
Table 45. China Key Players Avascular Necrosis Market Share (2019-2020)
Table 46. China Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 47. China Avascular Necrosis Market Share by Type (2015-2020)
Table 48. China Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 49. China Avascular Necrosis Market Share by Application (2015-2020)
Table 50. Japan Key Players Avascular Necrosis Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Avascular Necrosis Market Share (2019-2020)
Table 52. Japan Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Avascular Necrosis Market Share by Type (2015-2020)
Table 54. Japan Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Avascular Necrosis Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Avascular Necrosis Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Avascular Necrosis Market Share (2019-2020)
Table 58. Southeast Asia Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Avascular Necrosis Market Share by Type (2015-2020)
Table 60. Southeast Asia Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Avascular Necrosis Market Share by Application (2015-2020)
Table 62. India Key Players Avascular Necrosis Revenue (2019-2020) (Million US$)
Table 63. India Key Players Avascular Necrosis Market Share (2019-2020)
Table 64. India Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 65. India Avascular Necrosis Market Share by Type (2015-2020)
Table 66. India Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 67. India Avascular Necrosis Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Avascular Necrosis Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Avascular Necrosis Market Share (2019-2020)
Table 70. Central & South America Avascular Necrosis Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Avascular Necrosis Market Share by Type (2015-2020)
Table 72. Central & South America Avascular Necrosis Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Avascular Necrosis Market Share by Application (2015-2020)
Table 74. Stryker Company Details
Table 75. Stryker Business Overview
Table 76. Stryker Product
Table 77. Stryker Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 78. Stryker Recent Development
Table 79. Medtronic Company Details
Table 80. Medtronic Business Overview
Table 81. Medtronic Product
Table 82. Medtronic Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 83. Medtronic Recent Development
Table 84. Smith and Nephew Company Details
Table 85. Smith and Nephew Business Overview
Table 86. Smith and Nephew Product
Table 87. Smith and Nephew Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 88. Smith and Nephew Recent Development
Table 89. Ethicon Company Details
Table 90. Ethicon Business Overview
Table 91. Ethicon Product
Table 92. Ethicon Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 93. Ethicon Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Product
Table 102. Bayer Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 103. Bayer Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Product
Table 107. Pfizer Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 108. Pfizer Recent Development
Table 109. Merck Business Overview
Table 110. Merck Product
Table 111. Merck Company Details
Table 112. Merck Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 113. Merck Recent Development
Table 114. Boehringer Ingelheim Company Details
Table 115. Boehringer Ingelheim Business Overview
Table 116. Boehringer Ingelheim Product
Table 117. Boehringer Ingelheim Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 118. Boehringer Ingelheim Recent Development
Table 119. Eli Lilly Company Details
Table 120. Eli Lilly Business Overview
Table 121. Eli Lilly Product
Table 122. Eli Lilly Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 123. Eli Lilly Recent Development
Table 124. Aurobindo Pharma Company Details
Table 125. Aurobindo Pharma Business Overview
Table 126. Aurobindo Pharma Product
Table 127. Aurobindo Pharma Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 128. Aurobindo Pharma Recent Development
Table 129. Integra LifeSciences Company Details
Table 130. Integra LifeSciences Business Overview
Table 131. Integra LifeSciences Product
Table 132. Integra LifeSciences Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 133. Integra LifeSciences Recent Development
Table 134. Zimmer Biomet Company Details
Table 135. Zimmer Biomet Business Overview
Table 136. Zimmer Biomet Product
Table 137. Zimmer Biomet Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 138. Zimmer Biomet Recent Development
Table 139. Wright Medical Company Details
Table 140. Wright Medical Business Overview
Table 141. Wright Medical Product
Table 142. Wright Medical Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 143. Wright Medical Recent Development
Table 144. Grifols Company Details
Table 145. Grifols Business Overview
Table 146. Grifols Product
Table 147. Grifols Revenue in Avascular Necrosis Business (2015-2020) (Million US$)
Table 148. Grifols Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Avascular Necrosis Market Share by Type: 2020 VS 2026
Figure 2. Trauma Related Avascular Necrosis (AVN) Features
Figure 3. Non-Trauma Related Avascular Necrosis (AVN) Features
Figure 4. Global Avascular Necrosis Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Avascular Necrosis Report Years Considered
Figure 10. Global Avascular Necrosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Avascular Necrosis Market Share by Regions: 2020 VS 2026
Figure 12. Global Avascular Necrosis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Avascular Necrosis Market Share by Players in 2019
Figure 15. Global Top Avascular Necrosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avascular Necrosis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Avascular Necrosis Revenue in 2019
Figure 17. North America Avascular Necrosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Avascular Necrosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Avascular Necrosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Avascular Necrosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Avascular Necrosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Avascular Necrosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Avascular Necrosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
皮膚壊死治療の世界市場（～2026年） Acute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances of morbidity and loss of life. A thorough…- 腫瘍壊死因子α阻害剤の世界市場（～2026年） The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…
- 腫瘍壊死因子阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Market The global Tumor Necrosis Factor Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Scope and Market…
- 腫瘍壊死因子阻害薬の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Drug Market The global Tumor Necrosis Factor Inhibitors Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Drug S…
- 骨盤外傷管理の世界市場（～2026年） The management of pelvic trauma patients aims definitively to restore the homeostasis and the normal physiopathology associated to the mechanical stability of the pelvic ring. The management of pelvic trauma must be multidisciplinary and should be ultimately based on the physiology of the patient an…